Pelitinib is a potent, irreversible epidermal growth factor receptor (EGFR) inhibitor primarily investigated as an anticancer agent for treating solid tumors driven by EGFR mutations. Analytical laboratories… Read more
Pelitinib is a potent, irreversible epidermal growth factor receptor (EGFR) inhibitor primarily investigated as an anticancer agent for treating solid tumors driven by EGFR mutations. Analytical laboratories require high-quality Pelitinib reference standards to ensure accuracy and regulatory compliance during the development and production of this drug substance. These products are essential for rigorous impurity profiling, enabling the identification and quantification of process-related impurities and degradation products that may arise during synthesis or storage. Additionally, stable isotope labelled compounds are critical for advanced bioanalytical methods, serving as internal standards in mass spectrometry to enhance the sensitivity and precision of quantitative assays. By utilizing these characterized materials, pharmaceutical researchers can conduct robust method validation and maintain stringent quality control, ensuring that all testing protocols meet the necessary safety and efficacy benchmarks required for drug development and lifecycle management.